Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changchun Sanbang Pharmaceutical Technology is a specialized pharmaceutical enterprise located in Changchun, China, dedicated to the development and production of biochemical APIs and intermediates. The company is a significant manufacturer of animal-derived enzymes and proteins, including Aprotinin, Ulinastatin, and various pancreatic enzymes. Their operations emphasize high-purity extraction and purification technologies, adhering to international GMP standards to supply the global pharmaceutical industry. Beyond its core product portfolio, the company offers contract manufacturing and technical support for biochemical synthesis. Sanbang Pharmaceutical plays a key role in the supply chain for treatments targeting pancreatitis, cardiovascular conditions, and surgical complications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changchun Sanbang Pharmaceutical Technology.